These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18514083)

  • 1. Single-photon emission computed tomography and positron emission tomography evaluations of patients with central motor disorders.
    Seibyl JP
    Semin Nucl Med; 2008 Jul; 38(4):274-86. PubMed ID: 18514083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronuclear assessment of patients with epilepsy.
    Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W
    Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying neuroimaging ligands to study major depressive disorder.
    Meyer JH
    Semin Nucl Med; 2008 Jul; 38(4):287-304. PubMed ID: 18514084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional neuroimaging in movement disorders].
    Borbély K
    Orv Hetil; 2001 Oct; 142(43):2347-55. PubMed ID: 11760452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in evaluation of primary brain tumors.
    Chen W; Silverman DH
    Semin Nucl Med; 2008 Jul; 38(4):240-50. PubMed ID: 18514080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative movement disorders: the contribution of functional imaging.
    Piccini P
    Curr Opin Neurol; 2004 Aug; 17(4):459-66. PubMed ID: 15247543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiopharmaceuticals for single-photon emission computed tomography brain imaging.
    Kung HF; Kung MP; Choi SR
    Semin Nucl Med; 2003 Jan; 33(1):2-13. PubMed ID: 12605353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status and future challenges of brain imaging with (18)F-DOPA PET for movement disorders.
    Calabria FF; Calabria E; Gangemi V; Cascini GL
    Hell J Nucl Med; 2016; 19(1):33-41. PubMed ID: 26929938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments of dopaminergic imaging in Parkinson's disease.
    Varrone A; Halldin C
    Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):68-82. PubMed ID: 22460161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging studies in movement disorders.
    Seibyl JP
    Semin Nucl Med; 2003 Apr; 33(2):105-13. PubMed ID: 12756643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique roles of SPET brain imaging in clinical and research studies. Lessons from Parkinson's disease research.
    Seibyl J; Jennings D; Tabamo R; Marek K
    Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):215-21. PubMed ID: 16010256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Imaging Markers for Movement Disorders.
    Ghadery C; Strafella AP
    Curr Neurol Neurosci Rep; 2018 Apr; 18(5):22. PubMed ID: 29616343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging update: advances in MI of the brain.
    VanBrocklin H; Herscovitch P
    J Nucl Med; 2007 May; 48(5):24N, 29N. PubMed ID: 17475948
    [No Abstract]   [Full Text] [Related]  

  • 14. Single-photon emission computed tomography/computed tomography in brain tumors.
    Schillaci O; Filippi L; Manni C; Santoni R
    Semin Nucl Med; 2007 Jan; 37(1):34-47. PubMed ID: 17161038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracer development and hybrid imaging.
    Yang DJ; Kim EE
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1001-2. PubMed ID: 16086160
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroimaging methods applied in Parkinson's disease.
    Leenders KL
    J Neurol; 2004 Sep; 251 Suppl 6():VI/7-12. PubMed ID: 15675718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular basis of dopaminergic brain imaging in Parkinson's disease.
    Seibyl J; Russell D; Jennings D; Marek K
    Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):4-16. PubMed ID: 22460156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of SPECT in a time of PET.
    Jansen FP; Vanderheyden JL
    Nucl Med Biol; 2007 Oct; 34(7):733-5. PubMed ID: 17921025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating pathology in the brain with nuclear medicine.
    Silverman DH
    Semin Nucl Med; 2008 Jul; 38(4):225-6. PubMed ID: 18514078
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of neuroimaging in the early diagnosis and evaluation of Parkinson's disease.
    Seibyl J; Jennings D; Tabamo R; Marek K
    Minerva Med; 2005 Oct; 96(5):353-64. PubMed ID: 16227950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.